세계의 알레르기성 비염 시장 보고서(2025년)

Allergic Rhinitis Global Market Report 2025

US $ 4,490 ￦ 6,151,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,891,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,632,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

알레르기성 비염 시장 규모는 향후 몇 년 동안 안정적인 성장을 보일 것으로 예상되며, 2029년에는 4.1%의 CAGR로 184억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 예방 치료에 대한 수요, 고령화, 도시화, 의료비 지출에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 생물학적 제제 및 단클론항체, 디지털 건강 솔루션, 알레르기 항원 회피 전략, 소아 알레르기 비염, 알레르기 항원 검출 기술 등이 있습니다.

높은 수준의 대기 오염과 기후 변화는 알레르기 비염 시장의 성장을 크게 촉진할 것으로 예상됩니다. 대기 중 유해 물질로 특징지어지는 대기 오염은 호흡기 건강에 악영향을 미치며, 알레르기 비염의 보급률 증가에 기여하고 있습니다. 기온과 강수량이 장기적으로 변화하는 기후변화는 꽃가루와 같은 알레르겐의 빈도와 강도를 악화시켜 알레르기성 비염의 증상을 악화시킵니다. 이러한 연관성은 호흡기질환에 영향을 미치는 환경적 요인에 대한 관심의 증가를 강조합니다. 예를 들어, 2024년 8월 미국 환경보호청(EPA)은 2023년 미국 전역에서 약 6,600만 톤의 오염물질이 대기 중으로 배출되었다고 보고했습니다. 이러한 오염 수준의 증가는 기후 패턴의 변화와 함께 알레르기 비염의 발생률 증가로 이어질 것으로 예상되며, 이는 치료 및 관리 솔루션 시장의 성장을 촉진할 것으로 예상됩니다.

알레르기성 비염에 대한 부신피질 스테로이드 치료의 증가는 알레르기성 비염 시장의 성장을 크게 촉진할 것으로 예상됩니다. 비강내 염증을 억제하기 위해 일반적으로 사용되는 부신피질 스테로이드는 코막힘, 재채기, 가려움증과 같은 알레르기성 비염 증상을 완화하는 데 효과적입니다. 이 치료법은 염증을 억제하고 환자의 삶의 질을 향상시킬 수 있어 인기가 높아지고 있습니다. 예를 들어, 2023년 9월 미국 임상약리치료학회는 경구용 코르티코스테로이드 사용이 미국에서 평균 6.8%, 대만에서 17.5%, 덴마크에서 2.2%, 연간 증가율은 0.1%에서 0.17%라고 보고했습니다. 이러한 처방의 대부분은 단기간의 처방이었으며, 일반적으로 호흡기 감염과 같은 자기 제한적인 증상을 가진 건강한 성인에게 처방되었습니다. 부신피질 스테로이드의 사용은 지속적으로 증가하고 있으며, 치료 옵션을 늘리고 환자 결과를 개선함으로써 알레르기 비염 시장 확대에 더욱 기여할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 알레르기성 비염 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업 분석
• 세계의 알레르기성 비염 시장 : 성장률 분석
• 세계의 알레르기성 비염 시장 실적 : 규모와 성장, 2019-2024
• 세계의 알레르기성 비염 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 알레르기성 비염 전체 시장(TAM)

제6장 시장 세분화

• 세계의 알레르기성 비염 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 계절 알레르기성 비염
• 다년생 알레르기성 비염
• 직업적 알레르기성 비염
• 세계의 알레르기성 비염 시장 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 항히스타민제
• 코르티코스테로이드
• 면역요법
• 충혈제거제
• 기타 치료법
• 세계의 알레르기성 비염 시장 테스트에 의한 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 피부 테스트
• IgE 방사성 알레르기 흡착제(RAST) 검사
• 완전 혈구 계산
• 세계의 알레르기성 비염 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 경구
• 비강
• 기타 투여 경로
• 세계의 알레르기성 비염 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 소매 약국
• 온라인 스토어
• 세계의 알레르기성 비염 시장 계절성 알레르기성 비염 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 화분 알레르기
• 카비아레르기
• 세계의 알레르기성 비염 시장 통년성 알레르기성 비염 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 진드기 알레르기
• 반려동물 알레르기
• 카비아레르기
• 세계의 알레르기성 비염 시장 직업성 알레르기성 비염 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 화학 알레르겐
• 생물학적 알레르겐

제7장 지역별·국가별 분석

• 세계의 알레르기성 비염 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 알레르기성 비염 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 알레르기성 비염 시장 : 경쟁 구도
• 알레르기성 비염 시장 : 기업 개요
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi-Aventis LLC. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• GlaxoSmithKline plc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• UCB S.A.
• Sun Pharmaceutical Industries Limited
• Menarini Group
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Cipla Limited
• Endo Pharmaceuticals Inc.
• Zydus Lifesciences Ltd.
• Lupin Limited

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 알레르기성 비염 시장 2029 : 새로운 기회를 제공하는 국가
• 알레르기성 비염 시장 2029 : 새로운 기회를 제공하는 부문
• 알레르기성 비염 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Allergic rhinitis is a condition characterized by an allergic response that triggers nasal inflammation due to allergens like pollen, dust, mold, or pet dander. This allergic reaction leads to symptoms such as sneezing, nasal congestion, an itchy nose, and a sore throat. The management of allergic rhinitis involves the use of a range of allergy medications available in different dosage forms to alleviate these bothersome symptoms.

Allergic rhinitis can be categorized into several types, including seasonal allergic rhinitis (SAR), perennial allergic rhinitis, and occupational allergic rhinitis. SAR is characterized by the rapid onset and resolution of symptoms, often associated with allergens like pollen. The treatments for allergic rhinitis encompass various options such as antihistamines, corticosteroids, immunotherapy, and decongestants. Diagnosis and evaluation may involve different tests like skin tests, IgE radioallergosorbent tests, and complete blood counts. These treatments are administered through various routes, including oral and nasal administration. Moreover, they are accessible through diverse distribution channels such as hospital pharmacies, retail pharmacies, and online stores.

The allergic rhinitis market research report is one of a series of new reports from The Business Research Company that provides allergic rhinitis market statistics, including allergic rhinitis industry global market size, regional shares, competitors with an allergic rhinitis market share, detailed allergic rhinitis market segments, market trends and opportunities and any further data you may need to thrive in the allergic rhinitis industry. This allergic rhinitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The allergic rhinitis market size has grown steadily in recent years. It will grow from $15.22 billion in 2024 to $15.74 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to allergen exposure, environmental changes, public awareness, incresing pollution, research and developments on allergic rhinitis, rising disposable incomes.

The allergic rhinitis market size is expected to see steady growth in the next few years. It will grow to $18.49 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to demand for preventive treatments, aging population, urbanization, health care spending. Major trends in the forecast period include biologics and monoclonal antibodies, digital health solutions, allergen avoidance strategies, pediatric allergic rhinitis, allergen detection technology.

High levels of air pollution and climate change are expected to significantly drive the growth of the allergic rhinitis market. Air pollution, characterized by harmful substances in the atmosphere, adversely affects respiratory health, contributing to the increasing prevalence of allergic rhinitis. Climate change, with its long-term alterations in temperature and precipitation, can exacerbate the frequency and intensity of allergens like pollen, which in turn worsens the symptoms of allergic rhinitis. This connection underscores the rising concern about environmental factors influencing respiratory conditions. For instance, in August 2024, the United States Environmental Protection Agency (EPA) reported that approximately 66 million tons of pollutants were released into the atmosphere across the U.S. in 2023. These elevated pollution levels, along with changing climate patterns, are expected to lead to higher incidences of allergic rhinitis, thereby driving the growth of the market for treatments and management solutions.

The increase in corticosteroid treatment for allergic rhinitis is expected to significantly drive the growth of the allergic rhinitis market. Corticosteroids, commonly used to reduce inflammation in the nasal passages, are effective in relieving the symptoms of allergic rhinitis, such as congestion, sneezing, and itching. This treatment approach has become increasingly popular due to its ability to control inflammation and improve the quality of life for patients. For example, in September 2023, the American Society for Clinical Pharmacology and Therapeutics reported that oral corticosteroid use averaged 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark, with annual increases ranging from 0.1% to 0.17%. The majority of these prescriptions were for short bursts, typically for healthy adults with self-limited conditions like respiratory infections. As the use of corticosteroids continues to rise, it is expected to further contribute to the expansion of the allergic rhinitis market by enhancing treatment options and improving patient outcomes.

Prominent players within the allergic rhinitis market are actively engaged in the development of cutting-edge medications to maintain their market presence. For instance, in August 2022, Hikma Pharmaceuticals PLC, a pharmaceutical company based in the UK, and Glenmark Specialty S.A., a pharmaceutical company headquartered in Switzerland, received approval from the United States Food and Drug Administration (FDA), a federal agency based in the US, for their product known as Ryaltris. Ryaltris represents the first fixed-dose combination medication designed to alleviate both nasal and ocular symptoms of seasonal allergic rhinitis. It is conveniently administered as a nasal spray for adult and pediatric patients aged 12 and above. Notably, the relief from nasal symptoms begins within 15 minutes of the initial dose.

In January 2022, Glenmark Specialty S.A., a pharmaceutical company headquartered in Switzerland, established a partnership with Lotus International Pte. Ltd., a pharmaceutical company based in Singapore. Through this collaboration, Glenmark is set to introduce Ryaltris, an innovative nasal spray designed for allergic rhinitis treatment, into the markets of Singapore, Hong Kong, and Vietnam. Under this arrangement, Glenmark will be responsible for the manufacturing and supply of Ryaltris, while Lotus will oversee the commercialization of Ryaltris in these regions.

Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the allergic rhinitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allergic rhinitis market consists of revenues earned by entities by providing treatments such as alternative therapies, surgeries and lifestyle modifications. The market value includes the value of related goods sold by the service provider or included within the service offering. The allergic rhinitis market also includes sales of allergy pills and injections that are used for the treatment of the disease. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allergic Rhinitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergic rhinitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allergic rhinitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allergic rhinitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
• 2) By Treatment: Antihistamines; Corticosteroids; Immunotherapy; Decongestants; Other Treatments
• 3) By Test: Skin Test; IgE Radioallergosorbent (RAST) Test; Complete Blood Count
• 4) By Route Of Administration: Oral; Nasal; Other Route Of Administration
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores
• Subsegments:
• 1) By Seasonal Allergic Rhinitis: Pollen Allergy; Mold Allergy
• 2) By Perennial Allergic Rhinitis: Dust Mite Allergy; Pet Allergy; Mold Allergy
• 3) By Occupational Allergic Rhinitis: Chemical Allergens; Biological Allergens
• Companies Mentioned: Merck and Co. Inc.; Bayer AG; Novartis AG; Sanofi-Aventis LLC.; AstraZeneca PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Allergic Rhinitis Market Characteristics

3. Allergic Rhinitis Market Trends And Strategies

4. Allergic Rhinitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Allergic Rhinitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Allergic Rhinitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Allergic Rhinitis Market Growth Rate Analysis
• 5.4. Global Allergic Rhinitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Allergic Rhinitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Allergic Rhinitis Total Addressable Market (TAM)

6. Allergic Rhinitis Market Segmentation

• 6.1. Global Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis
• 6.2. Global Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Corticosteroids
• Immunotherapy
• Decongestants
• Other Treatments
• 6.3. Global Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Test
• IgE Radioallergosorbent (RAST) Test
• Complete Blood Count
• 6.4. Global Allergic Rhinitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Nasal
• Other Route Of Administration
• 6.5. Global Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• 6.6. Global Allergic Rhinitis Market, Sub-Segmentation Of Seasonal Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pollen Allergy
• Mold Allergy
• 6.7. Global Allergic Rhinitis Market, Sub-Segmentation Of Perennial Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dust Mite Allergy
• Pet Allergy
• Mold Allergy
• 6.8. Global Allergic Rhinitis Market, Sub-Segmentation Of Occupational Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Allergens
• Biological Allergens

7. Allergic Rhinitis Market Regional And Country Analysis

• 7.1. Global Allergic Rhinitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Allergic Rhinitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Allergic Rhinitis Market

• 8.1. Asia-Pacific Allergic Rhinitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Allergic Rhinitis Market

• 9.1. China Allergic Rhinitis Market Overview
• 9.2. China Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Allergic Rhinitis Market

• 10.1. India Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Allergic Rhinitis Market

• 11.1. Japan Allergic Rhinitis Market Overview
• 11.2. Japan Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Allergic Rhinitis Market

• 12.1. Australia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Allergic Rhinitis Market

• 13.1. Indonesia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Allergic Rhinitis Market

• 14.1. South Korea Allergic Rhinitis Market Overview
• 14.2. South Korea Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Allergic Rhinitis Market

• 15.1. Western Europe Allergic Rhinitis Market Overview
• 15.2. Western Europe Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Allergic Rhinitis Market

• 16.1. UK Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Allergic Rhinitis Market

• 17.1. Germany Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Allergic Rhinitis Market

• 18.1. France Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Allergic Rhinitis Market

• 19.1. Italy Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Allergic Rhinitis Market

• 20.1. Spain Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Allergic Rhinitis Market

• 21.1. Eastern Europe Allergic Rhinitis Market Overview
• 21.2. Eastern Europe Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Allergic Rhinitis Market

• 22.1. Russia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Allergic Rhinitis Market

• 23.1. North America Allergic Rhinitis Market Overview
• 23.2. North America Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Allergic Rhinitis Market

• 24.1. USA Allergic Rhinitis Market Overview
• 24.2. USA Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Allergic Rhinitis Market

• 25.1. Canada Allergic Rhinitis Market Overview
• 25.2. Canada Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Allergic Rhinitis Market

• 26.1. South America Allergic Rhinitis Market Overview
• 26.2. South America Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Allergic Rhinitis Market

• 27.1. Brazil Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Allergic Rhinitis Market

• 28.1. Middle East Allergic Rhinitis Market Overview
• 28.2. Middle East Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Allergic Rhinitis Market

• 29.1. Africa Allergic Rhinitis Market Overview
• 29.2. Africa Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Allergic Rhinitis Market Competitive Landscape And Company Profiles

• 30.1. Allergic Rhinitis Market Competitive Landscape
• 30.2. Allergic Rhinitis Market Company Profiles
  • 30.2.1. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi-Aventis LLC. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Allergic Rhinitis Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Viatris Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Regeneron Pharmaceuticals Inc.
• 31.6. UCB S.A.
• 31.7. Sun Pharmaceutical Industries Limited
• 31.8. Menarini Group
• 31.9. Perrigo Company plc
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Hikma Pharmaceuticals PLC
• 31.12. Cipla Limited
• 31.13. Endo Pharmaceuticals Inc.
• 31.14. Zydus Lifesciences Ltd.
• 31.15. Lupin Limited

32. Global Allergic Rhinitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allergic Rhinitis Market

34. Recent Developments In The Allergic Rhinitis Market

35. Allergic Rhinitis Market High Potential Countries, Segments and Strategies

• 35.1 Allergic Rhinitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Allergic Rhinitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Allergic Rhinitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료